Jiangxi Synergy Pharmaceutical Co Ltd (300636) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.028x

Based on the latest financial reports, Jiangxi Synergy Pharmaceutical Co Ltd (300636) has a cash flow conversion efficiency ratio of 0.028x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥65.40 Million ≈ $9.57 Million USD) by net assets (CN¥2.38 Billion ≈ $347.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 300636 stock market capitalisation for the company's overall valuation and market capitalisation.

Jiangxi Synergy Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Jiangxi Synergy Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangxi Synergy Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangxi Synergy Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Jiangxi Synergy Pharmaceutical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Apellis Pharmaceuticals Inc
NASDAQ:APLS
-0.147x
Paslin Digital Technology Co Ltd
SHG:600215
0.030x
Vietnam Construction and Import Export JSC
VN:VCG
-0.005x
Guizhou Yibai Pharmaceutical Co Ltd
SHG:600594
0.015x
Xerox Corp
NASDAQ:XRX
0.067x
Tianjin Ruixin Technology Co Ltd
SHE:300828
0.024x
Facc AG
VI:FACC
0.002x
WinMate Communication INC
TW:3416
0.004x

Annual Cash Flow Conversion Efficiency for Jiangxi Synergy Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Jiangxi Synergy Pharmaceutical Co Ltd from 2012 to 2025. View 300636 stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.37 Billion
≈ $346.11 Million
CN¥202.07 Million
≈ $29.57 Million
0.085x -30.84%
2024-12-31 CN¥2.31 Billion
≈ $337.84 Million
CN¥285.19 Million
≈ $41.73 Million
0.124x +67.95%
2023-12-31 CN¥2.23 Billion
≈ $325.80 Million
CN¥163.75 Million
≈ $23.96 Million
0.074x -50.48%
2022-12-31 CN¥1.32 Billion
≈ $193.11 Million
CN¥196.00 Million
≈ $28.68 Million
0.149x +0.43%
2021-12-31 CN¥888.11 Million
≈ $129.96 Million
CN¥131.34 Million
≈ $19.22 Million
0.148x +50.81%
2020-12-31 CN¥816.50 Million
≈ $119.48 Million
CN¥80.07 Million
≈ $11.72 Million
0.098x +344.98%
2019-12-31 CN¥706.31 Million
≈ $103.36 Million
CN¥-28.27 Million
≈ $-4.14 Million
-0.040x -135.16%
2018-12-31 CN¥658.16 Million
≈ $96.31 Million
CN¥74.93 Million
≈ $10.96 Million
0.114x +113.00%
2017-12-31 CN¥637.10 Million
≈ $93.23 Million
CN¥34.05 Million
≈ $4.98 Million
0.053x -73.06%
2016-12-31 CN¥304.66 Million
≈ $44.58 Million
CN¥60.45 Million
≈ $8.85 Million
0.198x -38.38%
2015-12-31 CN¥246.66 Million
≈ $36.09 Million
CN¥79.42 Million
≈ $11.62 Million
0.322x -41.08%
2014-12-31 CN¥118.02 Million
≈ $17.27 Million
CN¥64.50 Million
≈ $9.44 Million
0.547x +198.77%
2013-12-31 CN¥78.82 Million
≈ $11.53 Million
CN¥14.42 Million
≈ $2.11 Million
0.183x +406.36%
2012-12-31 CN¥45.51 Million
≈ $6.66 Million
CN¥-2.72 Million
≈ $-397.62K
-0.060x --

About Jiangxi Synergy Pharmaceutical Co Ltd

SHE:300636 China Drug Manufacturers - Specialty & Generic
Market Cap
$412.34 Million
CN¥2.82 Billion CNY
Market Cap Rank
#13363 Global
#3990 in China
Share Price
CN¥6.71
Change (1 day)
-1.47%
52-Week Range
CN¥6.30 - CN¥8.80
All Time High
CN¥15532.43
About

Jiangxi Synergy Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and fine chemicals in China and internationally. The company offers API products for anti-epilepsy and pain treatment, anti-inflammatory, gastrointestinal, anti-hypertension, anti-gout, anti-… Read more